Hantech Bio-Technology Co

Hantech Bio-Technology Co EBIT/Assets

The Operating Income to Assets Ratio (EBIT/Assets) of Hantech Bio-Technology Co (1294.TWO) as of Oct 28, 2026 is 14.88 %. In the previous year, Operating Income to Assets Ratio (EBIT/Assets) was 17.64 % — a change of -15.67% (lower).

EBIT/Assets

14.88 %

YoY

-15.67%

Last updated:

Operating Income to Assets Ratio (EBIT/Assets) of Hantech Bio-Technology Co is 2025 14.88 % . Operating Income to Assets Ratio (EBIT/Assets) of Hantech Bio-Technology Co was 2024 17.64 % . It decreases by -15.67% lower compared to the previous year.

The Hantech Bio-Technology Co EBIT/Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT/Assets
Date
EBIT/Assets
Jan 1, 2019
7.60 TWD
Jan 1, 2020
23.41 TWD
Jan 1, 2021
10.28 TWD
Jan 1, 2022
12.44 TWD
Jan 1, 2023
19.89 TWD
Jan 1, 2024
17.64 TWD
Jan 1, 2025
14.88 TWD
The Hantech Bio-Technology Co EBIT/Assets history
YEAREBIT/AssetsYoY
14.88 %-15.67%
17.64 %-11.28%
19.89 %+59.82%
12.44 %+21.04%
10.28 %-56.09%
23.41 %+208.02%
7.60 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Hantech Bio-Technology Co Stock analysis

What does Hantech Bio-Technology Co do? Hantech Bio-Technology Co., Ltd. generates revenue by manufacturing and selling science-based health products, eco-friendly pouches, and dietary supplements. The company provides functional drinks, including health drinks and crystal jelly, and powder raw materials and capsules such as pearl powder and tortoise-deer concentrated powder. Products are sold to markets in China, Southeast Asia, and America, with packaging options ranging from square bags to wine bottle bags in capacities of 10-80ml (g). The firm focuses on functional drink production, offering health drinks and crystal jelly in various shaped pouches like round mouth bottles, Z-shaped bags, and stand-up bags. Powder raw materials and capsule products include pearl powder and tortoise-deer concentrated powder, targeting consumers seeking health and wellness solutions. Sales are distributed across China, Southeast Asia, and American regions. Hantech Bio-Technology Co., Ltd. serves customers in China, Southeast Asia, and America through its eco-friendly packaging solutions and science-based health products. The company’s product portfolio includes functional drinks, crystal jelly, and dietary supplements with diverse packaging formats. Sales are driven by the demand for health-focused products in these key markets. Hantech Bio-Technology Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Hantech Bio-Technology Co stock

Operating Income to Assets Ratio (EBIT/Assets) of Hantech Bio-Technology Co is 14.88 % in 2025.

Operating Income to Assets Ratio (EBIT/Assets) of Hantech Bio-Technology Co changed from 17.64 % to 14.88 %, representing a -15.67% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Operating Income to Assets Ratio (EBIT/Assets) Hantech Bio-Technology Co since 2006 – with annual values, charts, and detailed analysis.

EBIT/Assets measures operating profitability relative to total assets, providing an unlevered view of asset efficiency that is comparable across capital structures.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Operating Income to Assets Ratio (EBIT/Assets)'s Hantech Bio-Technology Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Operating Income to Assets Ratio (EBIT/Assets)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Operating Income to Assets Ratio (EBIT/Assets).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Hantech Bio-Technology Co

All Key Metrics — Hantech Bio-Technology Co